obsolete tumors of body of uterus, with delivery

Based

Based on the provided context, it appears that there are limited resources available for information on obsolete tumors of the body of the uterus, specifically in relation to delivery.

However, I can provide some general information on symptoms related to uterine cancer and fibroids, which may be relevant to your query. Keep in mind that these conditions are not necessarily "obsolete" but rather, they are still present in modern medical contexts.

Symptoms of Uterine Cancer:

• Abnormal vaginal bleeding or discharge
• Pelvic pain or pressure
• Unusually heavy periods (menstruation)
• Vaginal spotting between periods

These symptoms can occur during early stages of uterine cancer, as mentioned in search result [10]. In more advanced stages, symptoms may include:

• Pain
• Bleeding
• Weight loss

Please note that these symptoms are not exclusive to uterine cancer and can be associated with other conditions.

Symptoms of Fibroids:

• Pelvic pain or pressure
• Painful sex
• Frequent urination (wee)
• Constipation

These symptoms can occur in women with fibroids, as mentioned in search result [2].

It's essential to consult a medical professional for accurate diagnosis and treatment. They will be able to assess your individual situation and provide guidance on the best course of action.

References:

[10] Irregular vaginal bleeding is the most common symptom of early-stage uterine cancer or uterine cancer that hasn't yet spread to other areas of the body, Pamela Soliman, MD, professor, and center ... [2] What are the symptoms of fibroids? · pain or pressure in your pelvis or lower back · painful sex · needing to urinate (wee) a lot · constipation.

Based on the provided context, it appears that you are looking for diagnostic tests related to obsolete tumors of the body of the uterus, specifically in the context of delivery.

Diagnostic Tests for Endometrial Cancer

According to search result [11], an endometrial biopsy is a diagnostic test where a sample of tissue is removed from the lining of the uterus. This test is often performed in a healthcare professional's office and involves sending the sample to a lab for testing to see if it is cancer.

Other Diagnostic Tests

Search result [13] mentions that the definitive diagnosis of endometrial cancer requires an endometrial tissue sample. Additionally, search result [14] notes that curettage has been considered the preferred method for obtaining a tissue sample, but the newer Pipelle method may also be used.

Imaging Studies

Search result [9] suggests that high-resolution gray-scale and color Doppler transvaginal scan is preferred generally, allowing for detailed assessment of the endometrium and myometrium. This imaging study can help identify any abnormalities in the uterus.

Blood Tests

Search result [10] mentions that testing the cancer cells for dMMR, MSI-H, and/or a high tumor mutational burden (TMB-H) might also be done to see if treatment with immunotherapy might be an option, especially for more advanced endometrial cancers. Additionally, search result [13] notes that a blood test known as a CA 125 assay can be used to check if the cancer has spread.

Staging Tests

Search result [15] mentions that further tests may be done to see if the cancer cells have spread within the uterus or to other parts of the body. These staging tests can include imaging studies, such as X-rays or CT scans, and blood tests like the CA 125 assay.

In summary, diagnostic tests for obsolete tumors of the body of the uterus, specifically in the context of delivery, may include:

• Endometrial biopsy
• Curettage (or Pipelle method)
• High-resolution gray-scale and color Doppler transvaginal scan
• Blood tests (CA 125 assay) to check for cancer spread
• Imaging studies (X-rays or CT scans) to stage the cancer

Please note that these diagnostic tests are not exhaustive, and a healthcare professional should be consulted for personalized advice.

Treatment Options for Uterine Fibroids

Uterine fibroids are benign tumors that can cause various symptoms in women. While there is no cure for fibroids, several treatment options are available to manage their growth and alleviate symptoms.

• Drug Delivery Systems: Research has shown promising results in using drug delivery systems to treat uterine fibroids. These systems involve delivering medications directly to the uterus, reducing the risk of side effects and improving efficacy.
• Ulipristal Acetate (UPA): UPA is a novel progesterone receptor modulator that has been introduced as an effective therapy for symptomatic fibroids. It works by blocking the action of progesterone, which can help reduce fibroid growth and alleviate symptoms.
• Mifepristone: Mifepristone has been found to have potential clinical applications in gynecological therapies, including endometriosis and uterine fibroids. It works by blocking the production of hormones that stimulate these conditions.

Intrauterine Delivery

Intrauterine delivery involves delivering medications directly to the uterus, which can be an effective way to treat infections and other conditions affecting the uterus. Research has shown promising results in using intrauterine delivery to treat infections, with improved pregnancy outcomes supporting its potential for treating other conditions.

• Antibiotics and Dexamethasone: Intrauterine delivery of antibiotics and dexamethasone has been shown to be effective in treating infections, with improved pregnancy outcomes supporting the potential of local delivery to treat other conditions.
• Persistent Local Drug Levels: Attaining persistent local drug levels for increased time can further improve the effectiveness of intrauterine delivery.

Other Treatment Options

In addition to drug delivery systems and intrauterine delivery, other treatment options are available for uterine fibroids. These include:

• Surgical Options: Surgical options such as myomectomy and hysterectomy may be necessary in severe cases.
• Therapeutic Treatment: Therapeutic treatments such as ulipristal acetate and leuprolide may also be effective.

References

1. Ekanem, E. (2021). Ulipristal Acetate: A Novel Progesterone Receptor Modulator for Symptomatic Fibroids. [Cited by 30]
2. Kuznetsova, MV. (2023). Treatment of Uterine Fibroids. [Cited by 2]
3. De La Cruz, MSYLD. (2017). Nonsteroidal Anti-inflammatory Drugs: A Medical Option for the Treatment of Uterine Fibroids. [Cited by 376]

Based on the provided context, it appears that you are looking for information on differential diagnosis of obsolete tumors of the body of the uterus, specifically in relation to delivery.

Key Points:

• The differential diagnosis mainly includes uterine smooth muscle tumors, particularly those displaying epithelioid morphology [9].
• Features in favor of a smooth muscle tumor include the presence of a vasculature varying in size and including thick-walled vessels, and the absence of melanocytic marker expression [9].
• Differential diagnoses also include diffuse uterine adenomyosis, diffuse endometrial hypertrophy, multiple leiomyomas, disseminated peritoneal leiomyomatosis, and others [10].

Clinical Relevance:

• The accuracy of dilatation and curettage (D&C) compared to pipelle endometrial biopsy in diagnosing a precancer, and excluding concurrent carcinoma, is unclear [11].
• Hysteroscopic and endometrial biopsy should be performed only in case of abnormal uterine bleeding or atypical ultrasound findings during follow-up [12].

Recent Insights:

• The landscape of uterine sarcomas is becoming increasingly complex with the description of new entities associated with recurrent molecular alterations [7].
• Recent discovery of new disease-defining molecular alterations and development of novel targeted therapies has dramatically changed the classification and management of uterine mesenchymal neoplasms [8].

Conclusion:

In conclusion, differential diagnosis of obsolete tumors of the body of the uterus involves considering various smooth muscle tumors, adenomyosis, endometrial hypertrophy, leiomyomas, and other entities. Accurate diagnosis is crucial for proper management and treatment.

References:

[9] Context 9 [10] Context 10 [11] Context 11 [7] Context 7 [8] Context 8